🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Digital Health Platform Blood Pressure Management Study

RecruitingNAAges 18 Years - 75 YearsAllTaipei Veterans General Hospital, Taiwan
NCT07147413 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This pilot study evaluated the effectiveness of an AI health education assistant compared to case manager support in hypertension management. Key outcomes included changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP), compliance with health behaviors, 722 goal achievement (monitoring, measurements, lifestyle improvements), and Technology Acceptance Model (TAM) metrics, including perceived usefulness (PU), perceived ease of use (PEU), and behavioral intention (BI). This study aims to examine whether the AI assistant group will achieve greater reductions in systolic and diastolic blood pressure compared to the case manager group. Additionally, it will evaluate whether the AI assistant group will demonstrate higher engagement in 722 goals and greater perceived ease of use. The results of this study are expected to provide further evidence supporting the potential of A

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Participants must meet all of the following criteria: 1. Aged 18 to 75 years at the time of enrollment 2. Able and willing to provide informed consent 3. Able to operate a mobile phone and interact with the digital platform 4. Willing to participate in home blood pressure monitoring Exclusion Criteria: Participants will be excluded if they meet any of the following criteria: 1. Systolic BP consistently \<120 mmHg and diastolic BP \<70 mmHg, based on baseline home monitoring (considered low BP not targeted in this study) 2. Pregnant or planning to become pregnant during the study period 3. Unable to operate a smartphone or digital device independently 4. Cognitive impairment or language barrier that prevents understanding of study procedures or informed consent 5. Severe comorbidities that may interfere with study participation or outcomes (e.g., advanced heart failure, end-stage renal disease) 6. Current participation in another interventional clinical study that could conflict with this protocol 7. Unwillingness to follow home blood pressure monitoring protocol or adhere to follow-up schedule
💊

What it tests

  • Behavioral/Digital Health Intervention
📍

Where

1 site
Taipei Veterans General Hospital
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy